Cite
HARVARD Citation
Janssen, Q. et al. (n.d.). Neoadjuvant FOLFIRINOX versus Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: Update on the Nationwide Multicenter PREOPANC-2 Randomized Trial. HPB. pp. S9-S10. [Online].